Dr Reddy's launches generic version of NitroDur transdermal infusion system in US
Business

Dr Reddy's launches generic version of NitroDur transdermal infusion system in US

Agency News

Hyderabad, Apr 14: Dr Reddy’s Laboratories Limited, along with its subsidiaries together on Tuesday announced the launch of authorized generic version of NitroDur (nitroglycerin) transdermal infusion system in the US market.

The combined market for all Nitrogylcerin Transdermal Patch products had US sales of approximately USD 14.7 million MAT for the most recent twelve months ending in January 2020 according to IQVIA Health, a company statement here said.

Dr Reddy’s Nitroglycerin Transdermal Infusion System is available in four dosage strengths: 0.1 mg/hr, 0.2 mg/hr, 0.4 mg/hr, and 0.6 mg/hr, each in a box of 30 count. (UNI)

pennews
www.pennews.net